Korean prostate cancer patients have worse disease characteristics than their American Counterparts

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6913-6917

  Kang, Dong Il ^a   Chung, Jae Il ^a   Ha, Hong Koo ^a   Min, Kweonsik ^a   Yoon, Jangho ^a   Kim, Wansuk ^a   Seo, Won Ik ^a   Kang, Pil Moon ^a   Jung, Soo Jin ^b   Kim, Isaac Yi ^c  

^a Pusan National University Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Neoplasm grading; Prostate; Prostatic neoplasm; Race; Risk; Specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; ASIAN; BLACK PERSON; BLOOD; CANCER GRADING; CANCER STAGING; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84892456251     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6913     Document Type: Article

References (13)

1. Anuurad E, Shiwaku K, Nogi A, et al (2003). The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health, 45, 335-43.
2. Center MM, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92.
3. Ilic D, Neuberger MM, Djulbegovic M (2013). Screening for prostate cancer. Cochrane Database Syst Rev, 1, CD004720.
4. Jung KW, Park S, Kong HJ(2012a). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat, 44, 11-24.
5. Jung KW, Park S, Won YJ, et al (2012b). Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat, 44, 25-31.
6. Kim D, Choi D, Lim JH, et al (2012). Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea. Korean J Urol, 53, 680-5.
7. Lin SS, Clarke CA, Prehn AW, et al (2002). Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer, 94, 1175-82.
8. Pan ZJ, Huang WJ, Zou ZH, et al (2012). The GSTT1 null genotype contributes to increased risk of prostate cancer in Asians: a meta-analysis. Asian Pac J Cancer Prev, 13, 2635-8.
9. Raymundo EM, Rice KR, Chen Y, et al (2011). Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system. BJU Int, 107, 1216-22.
10. Robbins AS, Koppie TM, Gomez SL, et al (2007). Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer, 110, 1255-63.
11. Siegel RD, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
12. Tabung F, Steck SE, Su LJ, et al (2012). Intake of grains and dietary fiber and prostate cancer aggressiveness by race. Prostate Cancer, 2012, 323296.
13. Wood LM, Pan ZK, Seavey MM, et al (2012). The ubiquitinlike protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy. Cancer Immunol Immunother, 61, 689-700.